COVID-19 Prognosis in Association with Antidepressant Use.

Min, Kyung Hyun; Kim, Tae Hyeok; Oh, Soo Jin; Kim, Woorim; Lee, Kyung Eun

Min, Kyung Hyun; Kim, Tae Hyeok; Oh, Soo Jin; Kim, Woorim; Lee, Kyung Eun.

Afiliação

Min KH; College of Pharmacy, Chungbuk National University, Cheongju-si, Republic of Korea.
Kim TH; College of Pharmacy, Chungbuk National University, Cheongju-si, Republic of Korea.
Oh SJ; College of Pharmacy, Chungbuk National University, Cheongju-si, Republic of Korea.
Kim W; College of Pharmacy, Chungbuk National University, Cheongju-si, Republic of Korea.
Lee KE; College of Pharmacy, Chungbuk National University, Cheongju-si, Republic of Korea.

Pharmacopsychiatry ; 55(4): 220-227, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35654396

Assuntos

COVID-19; Antidepressivos/efeitos adversos; Antidepressivos Tricíclicos/efeitos adversos; Humanos; Prognóstico; Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Pharmacopsychiatry Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google